{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T20:42:52Z","timestamp":1786221772801,"version":"build-2736575974"},"reference-count":68,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:00:00Z","timestamp":1778889600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["2017YQ061"],"award-info":[{"award-number":["2017YQ061"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007219","name":"Shanghai Municipal Natural Science Foundation","doi-asserted-by":"publisher","award":["23ZR1417200"],"award-info":[{"award-number":["23ZR1417200"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Shanghai Municipality Science and Technology Commission","doi-asserted-by":"publisher","award":["17YF1412200"],"award-info":[{"award-number":["17YF1412200"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Shanghai Municipality Science and Technology Commission","doi-asserted-by":"publisher","award":["23141902900"],"award-info":[{"award-number":["23141902900"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012600","name":"ShanghaiTech University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012600","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81702600"],"award-info":[{"award-number":["81702600"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21871086"],"award-info":[{"award-number":["21871086"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873436"],"award-info":[{"award-number":["81873436"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22171080"],"award-info":[{"award-number":["22171080"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21602060"],"award-info":[{"award-number":["21602060"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.apsb.2026.05.019","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T07:01:30Z","timestamp":1779433290000},"page":"5363-5382","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Novel noscapine derivative induces AML differentiation by dual-engaging DHODH and mitochondrial lipids to trigger a metabolic\u2013epigenetic\u2013transcriptional cascade"],"prefix":"10.1016","volume":"16","author":[{"given":"Shuting","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Defeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhao","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3125-9547","authenticated-orcid":false,"given":"Chuanxu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7210-4787","authenticated-orcid":false,"given":"Yongqiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8403-0236","authenticated-orcid":false,"given":"Qianqian","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2026.05.019_bib1","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1056\/NEJMra1406184","article-title":"Acute myeloid leukemia","volume":"373","author":"D\u00f6hner","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2026.05.019_bib2","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1001\/jamaoncol.2024.2662","article-title":"Contemporary management of acute myeloid leukemia: a review","volume":"10","author":"Venugopal","year":"2024","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.apsb.2026.05.019_bib3","doi-asserted-by":"crossref","DOI":"10.1080\/16078454.2023.2196482","article-title":"A review of treatment options employed in relapsed\/refractory AML","volume":"28","author":"Mohamed Jiffry","year":"2023","journal-title":"Hematology"},{"key":"10.1016\/j.apsb.2026.05.019_bib4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1182\/blood.2023022481","article-title":"How I treat refractory and relapsed acute myeloid leukemia","volume":"143","author":"Thol","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.apsb.2026.05.019_bib5","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1002\/cncr.31347","article-title":"How I treat older patients with acute myeloid leukemia","volume":"124","author":"Arellano","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.apsb.2026.05.019_bib6","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","article-title":"Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia","volume":"368","author":"Ley","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2026.05.019_bib7","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nrc2943","article-title":"Acute promyelocytic leukaemia: novel insights into the mechanisms of cure","volume":"10","author":"de Th\u00e9","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.apsb.2026.05.019_bib8","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41408-021-00514-3","article-title":"Acute promyelocytic leukemia current treatment algorithms","volume":"11","author":"Yilmaz","year":"2021","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.apsb.2026.05.019_bib9","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/s41408-021-00584-3","article-title":"Differentiation therapy for myeloid malignancies: beyond cytotoxicity","volume":"11","author":"Stubbins","year":"2021","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.apsb.2026.05.019_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115709","article-title":"Advances in acute myeloid leukemia differentiation therapy: a critical review","volume":"215","author":"Abdel-Aziz","year":"2023","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.apsb.2026.05.019_bib11","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s12964-022-01025-9","article-title":"The Warburg effect modulates DHODH role in ferroptosis: a review","volume":"21","author":"Amos","year":"2023","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.apsb.2026.05.019_bib12","doi-asserted-by":"crossref","first-page":"6936","DOI":"10.1111\/febs.16164","article-title":"The mitochondrial coenzyme Q junction and complex III: biochemistry and pathophysiology","volume":"289","author":"Banerjee","year":"2022","journal-title":"FEBS J"},{"key":"10.1016\/j.apsb.2026.05.019_bib13","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40170-021-00250-z","article-title":"DHODH and cancer: promising prospects to be explored","volume":"9","author":"Zhou","year":"2021","journal-title":"Cancer Metabol"},{"key":"10.1016\/j.apsb.2026.05.019_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2016.08.057","article-title":"Inhibition of dihydroorotate dehydrogenase overcomes differentiation blockade in acute myeloid leukemia","volume":"167","author":"Sykes","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2026.05.019_bib15","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.3324\/haematol.2019.230482","article-title":"ASLAN003, a potent dihydroorotate dehydrogenase inhibitor for differentiation of acute myeloid leukemia","volume":"105","author":"Zhou","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.apsb.2026.05.019_bib16","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1038\/s41375-019-0461-5","article-title":"The novel dihydroorotate dehydrogenase (DHODH) inhibitor BAY 2402234 triggers differentiation and is effective in the treatment of myeloid malignancies","volume":"33","author":"Christian","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.apsb.2026.05.019_bib17","doi-asserted-by":"crossref","first-page":"11254","DOI":"10.1021\/acs.jmedchem.4c00809","article-title":"Discovery of JNJ-74856665: a novel isoquinolinone DHODH inhibitor for the treatment of AML","volume":"67","author":"DeRatt","year":"2024","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2026.05.019_bib18","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1158\/1535-7163.MCT-20-0550","article-title":"Selective vulnerability to pyrimidine starvation in hematologic malignancies revealed by AG-636, a novel nlinical-stage inhibitor of dihydroorotate dehydrogenase","volume":"19","author":"McDonald","year":"2020","journal-title":"Mol Cancer Therapeut"},{"key":"10.1016\/j.apsb.2026.05.019_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.832816","article-title":"Emvododstat, a potent dihydroorotate dehydrogenase inhibitor, is effective in preclinical models of acute myeloid leukemia","volume":"12","author":"Branstrom","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.apsb.2026.05.019_bib20","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.3324\/haematol.2018.188185","article-title":"Pharmacological inhibition of dihydroorotate dehydrogenase induces apoptosis and differentiation in acute myeloid leukemia cells","volume":"103","author":"Wu","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.apsb.2026.05.019_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2025.123612","article-title":"Targeting vulnerability in tumor therapy: dihydroorotate dehydrogenase","volume":"371","author":"Lin","year":"2025","journal-title":"Life Sci"},{"key":"10.1016\/j.apsb.2026.05.019_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.chembiol.2017.12.012","article-title":"Lipids shape the electron acceptor-binding site of the peripheral membrane protein dihydroorotate dehydrogenase","volume":"25","author":"Costeira-Paulo","year":"2018","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.apsb.2026.05.019_bib23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/1535-7163.MCT-18-0863","article-title":"Targeting of hematologic malignancies with PTC299, a novel potent inhibitor of dihydroorotate dehydrogenase with favorable pharmaceutical properties","volume":"18","author":"Cao","year":"2019","journal-title":"Mol Cancer Therapeut"},{"key":"10.1016\/j.apsb.2026.05.019_bib24","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1080\/15257770.2022.2039393","article-title":"Protein\u2012lipid interactions of human dihydroorotate dehydrogenase and three mutants associated with Miller syndrome","volume":"41","author":"Orozco Rodriguez","year":"2022","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1016\/j.apsb.2026.05.019_bib25","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","article-title":"Natural products in drug discovery: advances and opportunities","volume":"20","author":"Atanasov","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.apsb.2026.05.019_bib26","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","article-title":"Natural products as sources of new drugs over the nearly four decades from 01\/1981 to 09\/2019","volume":"83","author":"Newman","year":"2020","journal-title":"J Nat Prod"},{"key":"10.1016\/j.apsb.2026.05.019_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114351","article-title":"Unraveling the therapeutic potential of natural products in the prevention and treatment of leukemia","volume":"160","author":"Goel","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.apsb.2026.05.019_bib28","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nchembio.935","article-title":"Adenanthin targets peroxiredoxin I and II to induce differentiation of leukemic cells","volume":"8","author":"Liu","year":"2012","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.apsb.2026.05.019_bib29","doi-asserted-by":"crossref","DOI":"10.1093\/hr\/uhac223","article-title":"Natural products of medicinal plants: biosynthesis and bioengineering in post-genomic era","volume":"9","author":"Guo","year":"2022","journal-title":"Hortic Res"},{"key":"10.1016\/j.apsb.2026.05.019_bib30","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.phytochem.2014.09.008","article-title":"Noscapine comes of age","volume":"111","author":"Chen","year":"2015","journal-title":"Phytochemistry"},{"key":"10.1016\/j.apsb.2026.05.019_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107831","article-title":"Synthesis and modification of noscapine derivatives as promising future anticancer agents","volume":"153","author":"Nemati","year":"2024","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.apsb.2026.05.019_bib32","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1007\/s10787-024-01447-6","article-title":"Curcumol: a review of its pharmacology, pharmacokinetics, drug delivery systems, structure\u2013activity relationships, and potential applications","volume":"32","author":"Zhai","year":"2024","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.apsb.2026.05.019_bib33","first-page":"13","article-title":"Pathology and immunology of acute leukemia","volume":"6","author":"Mirro","year":"1992","journal-title":"Leukemia"},{"key":"10.1016\/j.apsb.2026.05.019_bib34","doi-asserted-by":"crossref","first-page":"33035","DOI":"10.1074\/jbc.R400007200","article-title":"Mammalian pyrimidine biosynthesis: fresh insights into an ancient pathway","volume":"279","author":"Evans","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2026.05.019_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107115","article-title":"A novel mitochondria-targeting DHODH inhibitor induces robust ferroptosis and alleviates immune suppression","volume":"202","author":"Hai","year":"2024","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.apsb.2026.05.019_bib36","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2026.05.019_bib37","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1046\/j.1432-1327.2000.01213.x","article-title":"Requirements for the mitochondrial import and localization of dihydroorotate dehydrogenase","volume":"267","author":"Rawls","year":"2000","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.apsb.2026.05.019_bib38","doi-asserted-by":"crossref","first-page":"6707","DOI":"10.1038\/s41388-021-02058-z","article-title":"O-GlcNAc modified-TIP60\/KAT5 is required for PCK1 deficiency-induced HCC metastasis","volume":"40","author":"Liu","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.apsb.2026.05.019_bib39","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13072-023-00523-5","article-title":"O-GlcNAcylation: the sweet side of epigenetics","volume":"16","author":"Dupas","year":"2023","journal-title":"Epigenetics Chromatin"},{"key":"10.1016\/j.apsb.2026.05.019_bib40","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/s41419-024-06921-1","article-title":"Hexokinase HK3-mediated O-GlcNAcylation of EP300: a key regulator of PD-L1 expression and immune evasion in ccRCC","volume":"15","author":"Zhang","year":"2024","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.apsb.2026.05.019_bib41","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.3390\/cancers15041219","article-title":"The role of CREBBP\/EP300 and its therapeutic implications in hematological malignancies","volume":"15","author":"Zhu","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.apsb.2026.05.019_bib42","doi-asserted-by":"crossref","first-page":"19134","DOI":"10.1074\/jbc.M301580200","article-title":"Small molecule modulators of histone acetyltransferase p300","volume":"278","author":"Balasubramanyam","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2026.05.019_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.chembiol.2020.12.004","article-title":"Targeted degradation of the enhancer lysine acetyltransferases CBP and p300","volume":"28","author":"Vannam","year":"2021","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.apsb.2026.05.019_bib44","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1158\/1535-7163.MCT-20-0115","article-title":"Therapeutic vulnerabilities of transcription factors in AML","volume":"20","author":"Khan","year":"2021","journal-title":"Mol Cancer Therapeut"},{"key":"10.1016\/j.apsb.2026.05.019_bib45","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00018-013-1322-4","article-title":"Regulation of monocyte differentiation by specific signaling modules and associated transcription factor networks","volume":"71","author":"Huber","year":"2014","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.apsb.2026.05.019_bib46","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/s41573-022-00472-w","article-title":"Phenotypic drug discovery: recent successes, lessons learned and new directions","volume":"21","author":"Vincent","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.apsb.2026.05.019_bib47","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1021\/ml300464h","article-title":"SAR based optimization of a 4-quinoline carboxylic acid analog with potent anti-viral activity","volume":"4","author":"Das","year":"2013","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.apsb.2026.05.019_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2023.105681","article-title":"Advanced virtual screening enables the discovery of a host-targeting and broad-spectrum antiviral agent","volume":"217","author":"Chilingaryan","year":"2023","journal-title":"Antivir Res"},{"key":"10.1016\/j.apsb.2026.05.019_bib49","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a026534","article-title":"Exploitation of EP300 and CREBBP lysine acetyltransferases by cancer","volume":"7","author":"Attar","year":"2017","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.apsb.2026.05.019_bib50","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1038\/s41467-020-15221-z","article-title":"Chromatin accessibility promotes hematopoietic and leukemia stem cell activity","volume":"11","author":"Cabal-Hierro","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.05.019_bib51","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1038\/leu.2016.347","article-title":"Loss of p300 accelerates MDS-associated leukemogenesis","volume":"31","author":"Cheng","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.apsb.2026.05.019_bib52","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.tips.2024.01.010","article-title":"Histone lysine acetyltransferase inhibitors: an emerging class of drugs for cancer therapy","volume":"45","author":"White","year":"2024","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.apsb.2026.05.019_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116130","article-title":"Protein lysine acetyltransferase CBP\/p300: a promising target for small molecules in cancer treatment","volume":"171","author":"Gou","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.apsb.2026.05.019_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2019.08.006","article-title":"Unique and shared epigenetic programs of the CREBBP and EP300 acetyltransferases in germinal center B cells reveal targetable dependencies in lymphoma","volume":"51","author":"Meyer","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.apsb.2026.05.019_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2017.09.020","article-title":"mTORC1 phosphorylates acetyltransferase p300 to regulate autophagy and lipogenesis","volume":"68","author":"Wan","year":"2017","journal-title":"Mol Cell"},{"key":"10.1016\/j.apsb.2026.05.019_bib56","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/s41418-025-01473-z","article-title":"Crosstalk between O-GlcNAcylation and phosphorylation in metabolism: regulation and mechanism","volume":"32","author":"Zhao","year":"2025","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.apsb.2026.05.019_bib57","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.trecan.2018.10.003","article-title":"The MYC enhancer-ome: long-range transcriptional regulation of MYC in cancer","volume":"4","author":"Lancho","year":"2018","journal-title":"Trends Cancer"},{"key":"10.1016\/j.apsb.2026.05.019_bib58","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13045-019-0757-y","article-title":"Super-enhancers: critical roles and therapeutic targets in hematologic malignancies","volume":"12","author":"Jia","year":"2019","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.apsb.2026.05.019_bib59","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.1158\/0008-5472.CAN-13-0549","article-title":"O-GlcNAc transferase integrates metabolic pathways to regulate the stability of c-MYC in human prostate cancer cells","volume":"73","author":"Itkonen","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.apsb.2026.05.019_bib60","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1158\/2643-3230.BCD-20-0029","article-title":"TFEB links MYC signaling to epigenetic control of myeloid differentiation and acute myeloid leukemia","volume":"2","author":"Yun","year":"2021","journal-title":"Blood Cancer Discov"},{"key":"10.1016\/j.apsb.2026.05.019_bib61","first-page":"1133","article-title":"Myc-Miz1 signaling promotes self-renewal of leukemia stem cells by repressing Cebp\u03b1 and Cebp\u03b4","volume":"135","author":"Zhang","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.apsb.2026.05.019_bib62","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1034\/j.1600-0609.2001.00553.x","article-title":"FAB M4 and high CD14 surface expression is associated with high cellular resistance to Ara-C and daunorubicin: implications for clinical outcome in acute myeloid leukaemia","volume":"67","author":"N\u00f8rgaard","year":"2001","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.apsb.2026.05.019_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2022.101000","article-title":"Chasing leukemia differentiation through induction therapy, relapse and transplantation","volume":"57","author":"Saultz","year":"2023","journal-title":"Blood Rev"},{"key":"10.1016\/j.apsb.2026.05.019_bib64","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1182\/blood.2020005698","article-title":"A PML\/RAR\u03b1 direct target atlas redefines transcriptional deregulation in acute promyelocytic leukemia","volume":"137","author":"Tan","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.apsb.2026.05.019_bib65","doi-asserted-by":"crossref","first-page":"5665","DOI":"10.1038\/s41388-021-01952-w","article-title":"AML1\/ETO and its function as a regulator of gene transcription via epigenetic mechanisms","volume":"40","author":"Rejeski","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.apsb.2026.05.019_bib66","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1182\/blood-2011-10-386086","article-title":"Chromatin accessibility, p300, and histone acetylation define PML-RAR\u03b1 and AML1-ETO binding sites in acute myeloid leukemia","volume":"120","author":"Saeed","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.apsb.2026.05.019_bib67","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ccr.2009.12.045","article-title":"PML\/RARalpha targets promoter regions containing PU.1 consensus and RARE half sites in acute promyelocytic leukemia","volume":"17","author":"Wang","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.apsb.2026.05.019_bib68","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1128\/MCB.18.1.322","article-title":"The t(8;21) fusion product, AML-1-ETO, associates with C\/EBP-alpha, inhibits C\/EBP-alpha-dependent transcription, and blocks granulocytic differentiation","volume":"18","author":"Westendorf","year":"1998","journal-title":"Mol Cell Biol"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383526003126?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383526003126?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T19:59:48Z","timestamp":1786219188000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383526003126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":68,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2211383526003126"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2026.05.019","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel noscapine derivative induces AML differentiation by dual-engaging DHODH and mitochondrial lipids to trigger a metabolic\u2013epigenetic\u2013transcriptional cascade","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2026.05.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.","name":"copyright","label":"Copyright"}]}}